BRPI0921187A2 - bolo para administração de uma substância ativa a um animal e métodos para construir um bolo e para tratar um animal não humano - Google Patents

bolo para administração de uma substância ativa a um animal e métodos para construir um bolo e para tratar um animal não humano

Info

Publication number
BRPI0921187A2
BRPI0921187A2 BRPI0921187A BRPI0921187A BRPI0921187A2 BR PI0921187 A2 BRPI0921187 A2 BR PI0921187A2 BR PI0921187 A BRPI0921187 A BR PI0921187A BR PI0921187 A BRPI0921187 A BR PI0921187A BR PI0921187 A2 BRPI0921187 A2 BR PI0921187A2
Authority
BR
Brazil
Prior art keywords
cake
animal
administering
treating
making
Prior art date
Application number
BRPI0921187A
Other languages
English (en)
Inventor
Wayne Frederick Leech
William Ernest Pomroy
Original Assignee
Bomac Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bomac Research Ltd filed Critical Bomac Research Ltd
Publication of BRPI0921187A2 publication Critical patent/BRPI0921187A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0068—Rumen, e.g. rumen bolus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BRPI0921187A 2008-11-25 2009-06-29 bolo para administração de uma substância ativa a um animal e métodos para construir um bolo e para tratar um animal não humano BRPI0921187A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ573143A NZ573143A (en) 2008-11-25 2008-11-25 Improvements in delivery devices
PCT/NZ2009/000129 WO2010062190A1 (en) 2008-11-25 2009-06-29 Improvements in bolus devices for the delivery of active agents to animals

Publications (1)

Publication Number Publication Date
BRPI0921187A2 true BRPI0921187A2 (pt) 2016-02-23

Family

ID=42040796

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0921187A BRPI0921187A2 (pt) 2008-11-25 2009-06-29 bolo para administração de uma substância ativa a um animal e métodos para construir um bolo e para tratar um animal não humano

Country Status (8)

Country Link
US (2) US8329206B2 (pt)
EP (2) EP2361053B1 (pt)
AU (2) AU2009320500B2 (pt)
BR (1) BRPI0921187A2 (pt)
ES (1) ES2911226T3 (pt)
NZ (1) NZ573143A (pt)
WO (2) WO2010062190A1 (pt)
ZA (2) ZA201104724B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103126886A (zh) * 2011-05-13 2013-06-05 中国农业科学院北京畜牧兽医研究所 一种仔猪安抚剂释放盒
US11529310B2 (en) 2020-12-08 2022-12-20 Ruminant Biotech Corp Limited Devices and methods for delivery of substances to animals
AT528167A1 (de) 2024-03-15 2025-10-15 Smaxtec Animal Care Gmbh Sondenvorrichtung mit zumindest einer Reservoir-Einheit

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2416467A1 (fr) * 1978-02-03 1979-08-31 Ici Ltd Procede et appareil pour l'analyse de gaz
US4418686A (en) * 1979-08-01 1983-12-06 Child Laboratories Inc. Implant for inhibiting mastitis in dairy cattle
US4381780A (en) 1981-01-19 1983-05-03 Research Corporation Sustained release delivery system
NZ212100A (en) * 1984-06-02 1988-07-28 Castex Prod Rumen bolus; outer casing sheds in segments
GB8514666D0 (en) * 1985-06-11 1985-07-10 Coopers Animal Health Agent delivery systems
AU605482B2 (en) * 1986-04-17 1991-01-17 Castex Products Limited Pellet for administration to ruminants
US5219572A (en) * 1989-03-17 1993-06-15 Pitman-Moore, Inc. Controlled release delivery device for macromolecular proteins
GB9023270D0 (en) * 1990-10-25 1990-12-05 Castex Prod Magnesium manganese alloy
US5314696A (en) * 1991-06-27 1994-05-24 Paulos Manley A Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor
EP0739198B1 (en) * 1994-01-20 2003-09-17 Agresearch Limited Device for administration of beneficial materials to ruminants
GB9801141D0 (en) * 1998-01-21 1998-03-18 Porter William L Bolus for ruminent animals
US6030367A (en) * 1999-03-22 2000-02-29 Bracco Research Plunger rod
GB0111391D0 (en) * 2001-05-10 2001-07-04 Porter William L Pulse release bolus
NZ519363A (en) 2002-06-05 2004-02-27 Agres Ltd A novel drug dosing regimen
US7541048B2 (en) * 2004-04-06 2009-06-02 Surmodics, Inc. Coating compositions for bioactive agents

Also Published As

Publication number Publication date
ES2911226T3 (es) 2022-05-18
US8329206B2 (en) 2012-12-11
NZ573143A (en) 2010-03-26
AU2009320501A1 (en) 2011-07-07
AU2009320501B2 (en) 2014-08-21
EP2361053B1 (en) 2022-01-19
US20110280923A1 (en) 2011-11-17
EP2361055A4 (en) 2013-12-18
ZA201104723B (en) 2012-12-27
US20110287081A1 (en) 2011-11-24
WO2010062190A1 (en) 2010-06-03
ZA201104724B (en) 2012-12-27
AU2009320500B2 (en) 2014-09-25
EP2361053A4 (en) 2013-12-25
EP2361053A1 (en) 2011-08-31
EP2361055A1 (en) 2011-08-31
AU2009320500A1 (en) 2011-07-07
WO2010062191A1 (en) 2010-06-03

Similar Documents

Publication Publication Date Title
BRPI0907110A2 (pt) dispositivo de injeção para realizar injeções médicas
BRPI0914614A2 (pt) 2-arilaminoquinazolinas para tratar doenças proliferativas
BRPI0912431A2 (pt) Combinações de substâncias ativas sinergísticas
BRPI0822374A2 (pt) aparelhos e métodos para avaliar uma pessoa para um sistema de sono
BR112013011730A2 (pt) composição de oligossacarídeos para tratar doenças da pele
BRPI0908087A2 (pt) Composições e métodos para implante de tecido adipose e produtos de tecido adiposo
PT2582242T (pt) Combinações de substâncias ativas com propriedades inseticidas e acaricidas
BRPI0817907A8 (pt) aparelho para administrar uma substância a um indivíduo
BRPI0918299A2 (pt) Método para produzir um l-aminoácido
BRPI0906795A2 (pt) Método para produzir um l-aminoácido
CY2016053I2 (el) Μεθοδοι αγωγης χρησιμοποιωντας φαρμακευτικες ουσιες συλληψης αμμωνιας
DK2358756T4 (da) Humane antistoffer med høj affinitet til PCSK9
BR112013011874A2 (pt) compostos e métodos para tratar dor
BRPI0914902A2 (pt) composição farmacêutica e método para tratamento de mal de parkinson
BR112014005902A2 (pt) enfardadeira e método de enfardamento
BRPI0912755A2 (pt) Método para produzir um l-aminoácido
CO6801725A2 (es) Régimen escalonado de alimentación de lactantes para promover desarrollo y crecimiento sanos
BR112014007384A2 (pt) enfardadeira e método de enfardamento
BR112012001080A2 (pt) Combinações de substâncias ativas sinérgicas contendo feniltriazóis
BRPI1014528A2 (pt) compostos para tratamento de inflamação e dor
BR112012013801A2 (pt) composto,método para inibir a atividade de hidrolase de amida de ácido graxo em um indivíduo,composição farmacêutica e método para tratar um individuo com dor
BRPI1011912A2 (pt) l-serina para uso como medicamento para prevenir e/ou tratar uma reação inflamatória da pele.
BRPI1011394A2 (pt) 23método para avaliação de responsividade de linforma de células b ao tratamento com anticorpos anti-cd40
BRPI0821827A2 (pt) Derivados de beta-aminoácidos para tratamento de diabetes
SMT201600036B (it) Metodo per la preparazione e il miglioramento di ferri di cavallo

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BAYER NEW ZEALAND LIMITED (NZ)

B25G Requested change of headquarter approved

Owner name: BAYER NEW ZEALAND LIMITED (NZ)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2520 DE 25-04-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.